Shanghai - Delayed Quote CNY

Bloomage BioTechnology Corporation Limited (688363.SS)

52.61
-0.47
(-0.89%)
At close: 3:00:02 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,088,165.32
5,370,770.25
6,075,923.85
6,359,191.98
4,947,773.76
Cost of Revenue
1,362,564.29
1,392,561.67
1,621,027.89
1,463,226.84
1,085,252.31
Gross Profit
3,725,601.03
3,978,208.59
4,454,895.96
4,895,965.13
3,862,521.45
Operating Expense
3,490,244.05
3,569,088.16
3,717,209.24
3,785,433.92
2,948,108.57
Operating Income
235,356.98
409,120.42
737,686.73
1,110,531.22
914,412.88
Net Non Operating Interest Income Expense
3,882.71
3,984.79
26,893.72
23,470.74
12,547.68
Pretax Income
46,143.17
213,392.90
701,722.46
1,136,112
890,199.23
Tax Provision
19,988.73
44,986.99
118,980.43
174,731.80
114,643.18
Net Income Common Stockholders
32,793.46
174,267.40
592,555.91
970,918.59
782,334.57
Basic EPS
0.06
0.36
1.23
2.02
1.63
Diluted EPS
0.06
0.36
1.23
2.01
1.62
Basic Average Shares
486,080.05
484,076.11
481,752.77
480,652.77
479,959.86
Diluted Average Shares
486,080.05
484,076.11
481,752.77
483,044.08
482,922.58
Total Operating Income as Reported
49,450.32
215,939.71
708,385.55
1,136,313.78
905,553.29
Rent Expense Supplemental
--
65,458.06
62,142.07
51,559.74
11,074.47
Total Expenses
4,852,808.34
4,961,649.83
5,338,237.13
5,248,660.76
4,033,360.87
Net Income from Continuing & Discontinued Operation
32,793.46
174,267.40
592,555.91
970,918.59
782,334.57
Normalized Income
139,716.04
322,317.78
643,564.77
1,000,357.27
808,471.70
Interest Income
9,733.54
14,111.27
38,456.12
38,528.35
24,422.94
Interest Expense
9,777.13
9,173.36
10,735.73
14,523.04
11,084.64
Net Interest Income
3,882.71
3,984.79
26,893.72
23,470.74
12,547.68
EBIT
55,920.30
222,566.27
712,458.19
1,150,635.04
901,283.87
EBITDA
55,920.30
522,569.23
977,111.52
1,364,246.08
1,055,614.49
Reconciled Cost of Revenue
1,362,564.29
1,392,561.67
1,621,027.89
1,463,226.84
1,085,252.31
Reconciled Depreciation
--
300,002.97
264,653.34
213,611.04
154,330.62
Net Income from Continuing Operation Net Minority Interest
32,793.46
174,267.40
592,555.91
970,918.59
782,334.57
Total Unusual Items Excluding Goodwill
-178,204.31
-187,599.71
-61,423.51
-34,789.18
-30,000.74
Total Unusual Items
-178,204.31
-187,599.71
-61,423.51
-34,789.18
-30,000.74
Normalized EBITDA
234,124.60
710,168.95
1,038,535.04
1,399,035.26
1,085,615.23
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-71,281.72
-39,549.33
-10,414.65
-5,350.51
-3,863.61
12/31/2021 - 11/12/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade